This bulletin contains a selection of material gathered from a search of the evidence base, and is not intended to be comprehensive. Professional judgement should be exercised when appraising the material. NHS Greater Glasgow and Clyde libraries take no responsibility for the wording, content and accuracy of the information supplied, which has been extracted in good faith from reputable sources. NHSGGC is not responsible for the content of external internet sites.

The library network prefers to send information by email. Please only provide your address details if you wish to receive the articles (and future bulletins) by post. Please contact your library if you wish assistance in setting up an email account.

Please indicate below the number of any item you wish to order from this bulletin, and return this form to your local library. Or contact your local library directly. For library contact details please visit our website at It is preferred that articles are sent to you by email; please only complete your address details if you do not wish to receive articles/bulletins by email.

Identifying numbers of items requested I agree for my details to be held and processed in compliance with the Data Protection Act □

If you would like to receive additional bulletins, please tick the bulletins you would like to receive (there is no limit), ensure your name and email details (or address details) are on the front cover, and return to the library address given above.

A&E
Allied Health Professionals
Alzheimer’s disease
Ambulatory care
Anaesthesia
Asthma
Breast Cancer
Burns/Dermatology/Plastic Surgery
Cancer: Pain
Cancer Supportive Care
Cancer & the Young Adult
Chaplain
Child Protection
Clinical Governance
Community Child Health
Complaints
Coronary Intensive and High
Dependency Care (Nursing)
Corporate Services
Day surgery
A&E
Dental Care Professionals
Dentistry
Digestive Diseases
Elderly Care Bulletin (Nursing)
Epilepsy
Guidelines
Gynaecologic Oncology
Head Injury
Head & Neck Cancer
Health Promotion
Healthcare Associated Infection / Healthy Heart
IT
Lung Cancer
Medicine for the Elderly
Mental Health in the community
Multiple Sclerosis
Neonatal Nursing and Midwifery
New Books (all sites & Nursing/Midwifery)
New Nurse
Nursing in the community
Nutrition
Orthopaedics
Paediatric Anaesthesia & Pain
Paediatric Oncology Nursing
Paediatric Physiotherapy
Paediatric Respiratory Medicine
Parkinson’s disease
Pharmacy
Prevention & Treatment of Alcohol &
Drug Abuse (Nursing)
Rheumatology
Sarcoma
School Nurses
Speech and Language Therapy
Spinal Injuries
Stroke (North Glasgow)
Stroke (South Glasgow)
Training, Education and Management
(Nursing)

How to Access Electronic Articles

Many of the articles in this bulletin will be available online at the NHS Scotland eLibrary

  1. Go to the NHS Scotland eLibrary
  2. Click on Journals
  3. Type in the journal title and click search.
  4. Click on the appropriate title, and then select the supplier you wish to use.
  5. Put in your Athens password at the “Athens login” link.
  6. Select the correct year, volume, issue and page number for the article you want.

Please note that the journal articles you are accessing may be protected by copyright legislation and there may be a limit on the number of articles you can download or print from any single issue of a journal. If you obtain a copy via your local library's document request service, you may be required to complete a copyright declaration form. Consult your local library with any queries, or for further information see the website of the Copyright Licensing Agency at ."

Compiled by KIrsty Coltart

Library Manager

NHS Greater Glasgow & Clyde Library Network

Beatson West of Scotland Cancer Centre

Education Suite

1053 Great Western Road

G12 0YN

0141 301 7285

Journals received in the Beatson WoS Cancer Centre Library have been scanned for articles under the topics listed below. I have also included some titles held in other libraries in the Network and a few from OVID databases. Please use links where provided.

General

1.Amar, S. Treatment of metastatic breast cancer: Looking towards the future. Breast Cancer Research and Treatment 2009 114(3): 413-22

2.Balducci, L. Elderly patients with hormone sensitive breast cancer: What do the data show? Cancer Treatment Reviews 2009 35(1): 47-56

3.Frye DK. New options for metastatic breast cancer. Clinical Journal of Oncology Nursing. 13(1):11-8, 2009 Jan.

4.Kuerer HM. Ductal carcinoma in situ: state of the science and roadmap to advance the field. Journal of Clinical Oncology. 27(2):279-88, 2009 Jan 10.

5.Laird, B. Palliative Care in the Elderly Breast Cancer Patient. Clinical Oncology 2009 21(2):131-139

6.Mackey J. Adjuvant targeted therapy in early breast cancer. Cancer. 115(6):1154-68, 2009 Mar 15.

7.Mahon SM. Metastatic breast cancer: the individualization of therapy. Clinical Journal of Oncology Nursing. 13(1):19-28, 2009 Jan.

8.NICE Guidelines. Advanced breast cancer: diagnosis and treatment 2009 CG81

9.NICE Guidelines. Early and locally advanced breast cancer: diagnosis and treatment 2009. CG80

10.Palmieri FM. Current clinical issues in systemic therapy for metastatic breast cancer. Clinical Journal of Oncology Nursing. 13(1):4-10, 2009 Jan.

11.Sheppard, C. Breast cancer follow up: A randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. European Journal of Oncology Nursing 2009 13(1): 2-8

12.Tipples, K. Optimising Care of Elderly Breast Cancer Patients: a Challenging Priority. Clinical Oncology 2009 21(2): 118-130

Combined Modality Therapies

13.Cancer and Leukemia Group B .Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: A phase II trial (CALGB 8944). Breast Cancer Research and Treatment 2009 113(3): 479-90

14.Chen, J. Impact of MRI-Evaluated Neoadjuvant Chemotherapy Response on Change of Surgical Recommendation in Breast Cancer. Annals of Surgery. 249(3):448-454, March 2009.

15.Diepenmaat, L. The impact of postmastectomy radiotherapy on local control in patients with invasive lobular breast cancer. Radiotherapy and Oncology 2009 91(1): 49-53

16.Floyd, S. Post-mastectomy radiation in large node-negative breast tumors: Does size really matter?Radiotherapy and Oncology 2009 91(1): 33-37

17.Holli K. Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial. Journal of Clinical Oncology. 27(6):927-32, 2009 Feb 20.

18.Magne, N. Special focus on cardiac toxicity of different sequences of adjuvant doxorubicin/docetaxel/CMF regimens combined with radiotherapy in breast cancer patients. Radiotherapy and Oncology 2009 90(1): 116-121

19.Mannino, M. Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: Can radiotherapy ever be safely withheld?Radiotherapy and Oncology 2009 90(1): 14-22

21.Poortmans, P. Impact of the boost dose of 10Gy versus 26Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. Radiotherapy and Oncology 2009 90(1): 80-85

20.Rowell, N. Radiotherapy to the chest wall following mastectomy for node-negative breast cancer: A systematic review.Radiotherapy and Oncology 2009 91(1): 23-32

21.Truong, P. Patients With T1 to T2 Breast Cancer With One to Three Positive Nodes Have Higher Local and Regional Recurrence Risks Compared With Node-Negative Patients After Breast-Conserving Surgery and Whole-Breast Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 2009 73(2): 357-364

Drug Therapy

22.Andreetta, C. Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer. Annals of Oncology 2009 20(2): 265-71

23.de Azambuja E. Long-term benefit of high-dose epirubicin in adjuvant chemotherapy for node-positive breast cancer: 15-year efficacy results of the belgian multicentre study. Journal of Clinical Oncology. 27(5):720-5, 2009 Feb 10.

24.Barnadas A. Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial. British Journal of Cancer. 100(3):442-9, 2009 Feb 10.

25.Baselga J. Phase II genomics study of ixabepilone as neoadjuvant treatment for breast cancer. Journal of Clinical Oncology. 27(4):526-34, 2009 Feb 1.

26.Chirivella, I. Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients. Breast Cancer Research and Treatment 2009 114(3): 479-84

27.Frye DK. Capecitabine-based combination therapy for breast cancer:implications for nurses. Oncology Nursing Forum. Online. 36(1):105-13, 2009 Jan.

28.Gnant, M. Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer. New England Journal of Medicine. 360(7):679-691, February 12, 2009.

29.Hackshaw A. Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer. Journal of the National Cancer Institute. 101(5):341-9, 2009 Mar 4.

30.Hugh J. Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial. Journal of Clinical Oncology. 27(8):1168-76, 2009 Mar 10.

31.Jones RL. A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer. British Journal of Cancer. 100(2):305-10, 2009 Jan 27.

32.Mariani G. Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer. Nature Clinical Practice Oncology. 6(2):93-104, 2009 Feb.

33.Mathew, J. Neoadjuvant chemotherapy for locally advanced breast cancer: A review of the literature and future directions. European Journal of Surgical Oncology (EJSO) 2009 35(2): 113-122

34.Nielsen, D. HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors. Cancer Treatment Reviews 2009 35(2): 121-136

35.Nieto, Y. High-dose chemotherapy for high-risk primary and metastatic breast cancer: is another look warranted?. Current Opinion in Oncology. 21(2):150-157, March 2009.

36.Ortmann, O. Adjuvant endocrine therapy for perimenopausal women with early breast cancer. The Breast 2009 18(1): 2-7

37.Prati R. Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy. Cancer. 115(6):1194-202, 2009 Mar 15.

38.Sullivan, P. Should Histologic Type be Taken into Account when Considering Neoadjuvant Chemotherapy in Breast Carcinoma?. Breast Journal. 15(2):146-154, March/April 2009.

Pathology, Staging, Polymorphisms & Biomarkers

39.Brown SB. Is the biology of breast cancer changing? A study of hormone receptor status 1984-1986 and 1996-1997. British Journal of Cancer. 100(5):807-10, 2009 Mar 10.

40.Chang, H. Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients. Annals of Oncology 2009 20(2): 272-77

41.Farmer P. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nature Medicine. 15(1):68-74, 2009 Jan.

42.Generali D. Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer. Journal of Clinical Oncology. 27(2):227-34, 2009 Jan 10.

43.Gur-Dedeoglu B. A resampling-based meta-analysis for detection of differential gene expression in breast cancer. BMC Cancer. 8:396, 2008.

44.Markopoulos, C. Lipid changes in breast cancer patients on exemestane treatment: final results of the TEAM Greek substudy. Annals of Oncology 2009 20(1): 49-55

45.Patani, N. The clinical significance of sentinel lymph node micrometastasis in breast cancer. Breast Cancer Research and Treatment 2009 114(3): 393-402

46.Rahka, E. Patho-biological aspects of basal-like breast cancer.Breast Cancer Research and Treatment 2009 113(3): 411-22

47.Reinholz, M. Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response.The Lancet Oncology 2009 10(3): 267-277

48.Sotiriou, C. Gene-Expression Signatures in Breast Cancer. New England Journal of Medicine. 360(8):790-800, February 19, 2009.

49.Sullivan, C. Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer. Human Pathology 2009 40(2):156-165

50.Thomas, G. How Age Affects the Biology of Breast Cancer. Clinical Oncology 2009 21(2):81-85

51.Van der Vegt, B. Microarray methods to identify factors determining breast cancer progression: Potentials, limitations, and challenges. Critical Reviews in Oncology/Hematology 2009 70(1): 1-11

Prognosis, Survival & Risk Factors

52.Beadle, B. Ten-Year Recurrence Rates in Young Women With Breast Cancer by Locoregional Treatment Approach. International Journal of Radiation Oncology*Biology*Physics 2009 73(1): 734-744

53.Chlebowski, R. Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women. New England Journal of Medicine. 360(6):573-587, February 5, 2009.

54.Gunter MJ. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. Journal of the National Cancer Institute. 101(1):48-60, 2009 Jan 7.

55.Kyndi, M. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c. Radiotherapy and Oncology 2009 90(1): 74-79

56.Lu, W. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: A meta-analysis. Breast Cancer Research and Treatment 2009 114(3): 403-12

57.Rudloff U. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy. Cancer. 115(6):1203-14, 2009 Mar 15.

58.Schmidt, M. Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer_comparison between Adjuvant St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial. Annals of Oncology 2009 20(2): 258-64

59.Sternfeld B. Physical Activity and Risk of Recurrence and Mortality in Breast Cancer Survivors: Findings from the LACE Study. Cancer Epidemiology, Biomarkers & Prevention. 18(1):87-95, 2009 Jan.

60.van Nes JG. Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients. British Journal of Cancer. 100(3):494-500, 2009 Feb 10.

Radiotherapy & Imaging

61.Alonso-Basanta, M. Coverage of Axillary Lymph Nodes in Supine vs. Prone Breast Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 2009 73(1): 745-751

62.Aristei, C. Computed tomography for excision cavity localization and 3D-treatment planning in partial breast irradiation with high-dose-rate interstitial brachytherapy. Radiotherapy and Oncology 2009 90(1): 43-47

63.Berrang, T. 3D Ultrasound Can Contribute to Planning CT to Define the Target for Partial Breast Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 2009 73(2): 375-383

64.Caudrelier, JM. Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: Dosimetric evaluation. Radiotherapy and Oncology 2009 90(1): 99-105

65.Dickler, A. Xoft Axxent® electronic brachytherapy_a new device for deliveringbrachytherapy to the breast. Nature Clinical Practice Oncology 2009 6(3): 138-42

66.Demirci, S. Radiation-Induced Cardiac Toxicity After Therapy for Breast Cancer: Interaction Between Treatment Era and Follow-Up Duration. International Journal of Radiation Oncology*Biology*Physics 2009 73(4):980-987

67.Garg, A. Effects of Variable Placement of Superior Tangential/Supraclavicular Match Line on Dosimetric Coverage of Level III Axilla/Axillary Apex in Patients Treated With Breast and Supraclavicular Radiotherapy.International Journal of Radiation Oncology*Biology*Physics 2009 73(2): 370-374

68.Goddo, SM. Helical Tomotherapy Planning for Left-Sided Breast Cancer Patients With Positive Lymph Nodes: Comparison to Conventional Multiport Breast Technique. International Journal of Radiation Oncology*Biology*Physics 2009 73(4): 1243-1251

69.Harris, E. Characterization of Target Volume Changes During Breast Radiotherapy Using Implanted Fiducial Markers and Portal Imaging. International Journal of Radiation Oncology*Biology*Physics 2009 73(1): 958-966

70.Hurkmans, C. Significance of breast boost volume changes during radiotherapy in relation to current clinical interobserver variations. Radiotherapy and Oncology 2009 90(1): 60-65

71.Jain, P. Inter-fraction motion and dosimetric consequences during breast intensity-modulated radiotherapy (IMRT) Radiotherapy and Oncology 2009 90(1):93-98

72.Johansson, B. Pulsed dose rate brachytherapy as the sole adjuvant radiotherapy after breast-conserving surgery of T1–T2 breast cancer: First long time results from a clinical study. Radiotherapy and Oncology 2009 90(1): 30-35

73.Kunkler, I. Breast Radiotherapy: Considerations in Older Patients. Clinical Oncology 2009 21(2):111-117

74.Li, XA. Variability of Target and Normal Structure Delineation for Breast Cancer Radiotherapy: An RTOG Multi-Institutional and Multiobserver Study. International Journal of Radiation Oncology*Biology*Physics 2009 73(1): 944-951

75.Livi, L. Radiotherapy Timing in 4,820 Patients With Breast Cancer: University of Florence Experience. International Journal of Radiation Oncology*Biology*Physics 2009 73(2):

365-369

76.Lukens, JN. Regional Nodal Recurrence After Breast Conservation Treatment With Radiotherapy for Women With Early-Stage Breast Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2009 73(5):1475-1481

77.Major, T. Dosimetric experience with accelerated partial breast irradiation using image-guided interstitial brachytherapy. Radiotherapy and Oncology 2009 90(1):48-55

78.Mannino, M. Accelerated partial breast irradiation trials: Diversity in rationale and design. Radiotherapy and Oncology 2009 91(1): 16-22

79.Miles, E. Dosimetry and field matching for radiotherapy to the breast and supraclavicular fossa. Radiotherapy and Oncology 2009 91(1): 42-48

80.Moon, SH. Dosimetric comparison of four different external beam partial breast irradiation techniques: Three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy. Radiotherapy and Oncology 2009 90(1): 66-73

81.Morganti, A. Phase I–II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. Radiotherapy and Oncology 2009 90(1): 86-92

82.Nguyen, B. Practical Applications of Nuclear Medicine in Imaging Breast Cancer. Current Problems in Diagnostic Radiology 2009 38(2): 68-83

83.Offersen, B. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: A systematic review. Radiotherapy and Oncology 2009 90(1):1-13

84.Pignol, JP. Tolerance and Acceptance Results of a Palladium-103 Permanent Breast Seed Implant Phase I/II Study. International Journal of Radiation Oncology*Biology*Physics 2009 73(5): 1482-1488

85.Reed, V. Automatic Segmentation of Whole Breast Using Atlas Approach and Deformable Image Registration. International Journal of Radiation Oncology*Biology*Physics 2009 73(5): 1493-1500

86.Richards, G. Pulsed reduced dose-rate radiotherapy: A novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region. Breast Cancer Research and Treatment 2009 114(2): 307-313

87.Scanderberg, D. Clinical implementation of a new HDR brachytherapy device for partial breast irradiation. Radiotherapy and Oncology 2009 90(1): 36-42

88.Schwarz-Dose J. Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose. Journal of Clinical Oncology. 27(4):535-41, 2009 Feb 1.

89.Taylor, C. Estimating Cardiac Exposure From Breast Cancer Radiotherapy in Clinical Practice. International Journal of Radiation Oncology*Biology*Physics 2009 73(4): 1061-1068

90.Thomas, C. An anthropomorphic phantom study of visualisation of surgical clips for partial breast irradiation (PBI) setup verification. Radiotherapy and Oncology 2009 90(1): 56-59